Extensively drug-resistant Acinetobacter baumannii
- PMID: 19523312
- PMCID: PMC2727341
- DOI: 10.3201/eid1506.081006
Extensively drug-resistant Acinetobacter baumannii
Comment in
-
Optimal therapy for multidrug-resistant Acinetobacter baumannii.Emerg Infect Dis. 2010 Jan;16(1):170; author reply 170-1. doi: 10.3201/eid1601.091467. Emerg Infect Dis. 2010. PMID: 20031080 Free PMC article. No abstract available.
Similar articles
-
Role of combination antibiogram in empirical treatment of infection due to multidrug-resistant Acinetobacter baumannii.Infect Control Hosp Epidemiol. 2008 Jul;29(7):678-9. doi: 10.1086/588681. Infect Control Hosp Epidemiol. 2008. PMID: 18624670 No abstract available.
-
Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance.J Med Assoc Thai. 2009 Aug;92 Suppl 4:S34-45. J Med Assoc Thai. 2009. PMID: 21294501
-
Overcoming challenges of treating extensively drug-resistant Acinetobacter baumannii bacteraemic urinary tract infection.Int J Antimicrob Agents. 2018 Oct;52(4):521-522. doi: 10.1016/j.ijantimicag.2018.07.016. Epub 2018 Aug 4. Int J Antimicrob Agents. 2018. PMID: 30081140 No abstract available.
-
Confronting multidrug-resistant Acinetobacter baumannii: a review.Int J Antimicrob Agents. 2011 Feb;37(2):102-9. doi: 10.1016/j.ijantimicag.2010.10.014. Epub 2010 Dec 4. Int J Antimicrob Agents. 2011. PMID: 21130607 Review.
-
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.Nat Rev Microbiol. 2007 Dec;5(12):939-51. doi: 10.1038/nrmicro1789. Nat Rev Microbiol. 2007. PMID: 18007677 Review.
Cited by
-
Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains.Antimicrob Agents Chemother. 2013 May;57(5):2103-8. doi: 10.1128/AAC.02501-12. Epub 2013 Feb 19. Antimicrob Agents Chemother. 2013. PMID: 23422916 Free PMC article.
-
Engineered phage enzymes against drug-resistant pathogens: a review on advances and applications.Bioprocess Biosyst Eng. 2024 Mar;47(3):301-312. doi: 10.1007/s00449-023-02938-6. Epub 2023 Nov 14. Bioprocess Biosyst Eng. 2024. PMID: 37962644 Review.
-
Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis.Infect Immun. 2010 May;78(5):1952-62. doi: 10.1128/IAI.00889-09. Epub 2010 Mar 1. Infect Immun. 2010. PMID: 20194595 Free PMC article.
-
Trans-Cinnamaldehyde and Eugenol Increase Acinetobacter baumannii Sensitivity to Beta-Lactam Antibiotics.Front Microbiol. 2018 May 23;9:1011. doi: 10.3389/fmicb.2018.01011. eCollection 2018. Front Microbiol. 2018. PMID: 29875743 Free PMC article.
-
Antimicrobial Activity of Gallium Protoporphyrin IX against Acinetobacter baumannii Strains Displaying Different Antibiotic Resistance Phenotypes.Antimicrob Agents Chemother. 2015 Dec;59(12):7657-65. doi: 10.1128/AAC.01472-15. Epub 2015 Sep 28. Antimicrob Agents Chemother. 2015. PMID: 26416873 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources